E2007

Phase 3Completed

2 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Partial Onset Seizures

Conditions

Partial Onset Seizures

Trial Timeline

Jun 28, 2017 → Jul 27, 2020

NCT ID

NCT03201900

About E2007

E2007 is a phase 3 stage product being developed by Eisai for Partial Onset Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT03201900. Target conditions include Partial Onset Seizures.

What happened to similar drugs?

18 of 20 similar drugs in Partial Onset Seizures were approved

Approved (18) Terminated (5) Active (2)

✅Perampanel + PlaceboEisaiApproved

✅Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved

✅PerampanelEisaiApproved

✅Eslicarbazepine acetate + Eslicarbazepine AcetateSumitomo PharmaApproved

✅OxcarbazepineNovartisApproved

✅Hydrocortisone + PlaceboNovo NordiskApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (10)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03201900	Phase 3	Completed	Jun 28, 2017	Jul 27, 2020	Partial Onset Seizures
NCT02116907	Phase 1	Completed	May 1, 2014	Sep 1, 2014	Healthy Subjects
NCT00849212	Phase 2	Completed	Apr 1, 2009	Nov 1, 2009	Refractory Partial Seizures
NCT00592904	Phase 2/3	Completed	Jan 1, 2008	Jul 1, 2011	Neuralgia
NCT00451633	Phase 2	Withdrawn	Mar 1, 2007	—	Parkinson's Disease
NCT00427011	Phase 2	Terminated	Feb 1, 2007	Apr 1, 2008	Parkinson's Disease
NCT00360412	Phase 3	Terminated	Oct 1, 2006	Apr 1, 2008	Parkinson's Disease
NCT00286897	Phase 3	Completed	Feb 1, 2006	Aug 1, 2007	Parkinson's Disease
NCT00165789	Phase 2	Completed	Sep 1, 2005	Sep 1, 2006	Parkinson's Disease
NCT00154063	Phase 2	Completed	Jan 1, 2005	Jun 1, 2006	Migraine Prophylaxis

Competing Products

20 competing products in Partial Onset Seizures

See all competitors

Product	Company	Stage	Hype Score
Perampanel	Eisai	Pre-clinical	26
perampanel + perampanel	Eisai	Phase 1	29
perampanel + perampanel + perampanel + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Approved	35
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
perampanel	Eisai	Phase 2	35
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide	Eisai	Pre-clinical	26
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Phase 3	40
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Adjunctive Zonisamide + Replacement with Zonisamide	Eisai	Approved	43
Fycompa	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
Fycompa	Eisai	Pre-clinical	26
Rufinamide	Eisai	Phase 3	32
Zonisamide	Eisai	Phase 3	40
Eslicarbazepine Acetate tablets	Eisai	Pre-clinical	26
Perampanel	Eisai	Pre-clinical	26